West Pharmaceutical Services Inc
West Pharmaceutical Services Inc/ US9553061055 /
WST
2024-04-25 9:59:58 PM
|
Chg.
-17.12
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
368.42USD
|
-4.44%
|
31,286 Turnover: 11.66 mill. |
-Bid Size: - |
-Ask Size: - |
26.99 bill.USD |
0.21% |
46.14 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
7.98 USD |
1.40% |
EPS Diluted: |
7.88 USD |
1.94% |
Revenues per Share: |
40.24 USD |
3.34% |
Book Value per Share: |
39.30 USD |
8.53% |
Cash Flow per Share: |
10.59 USD |
8.48% |
Dividend per Share: |
0.78 USD |
5.41% |
Total |
in mill. |
|
Revenues: |
2,949.80 USD |
2.18% |
Net Income: |
593.40 USD |
1.28% |
Operating Cash Flow: |
776.50 USD |
- |
Cash and Cash Equivalents: |
853.90 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
46.14 |
44.13 |
P/S Ratio: |
9.15 |
8.75 |
P/BV ratio: |
9.37 |
8.96 |
P/CF Ratio: |
34.76 |
33.24 |
PEG: |
33.01 |
31.57 |
Earnings Yield: |
2.17% |
2.27% |
Dividend Yield: |
0.21% |
0.22% |
Market Capitalization |
|
Market Capitalization: |
26.99 bill. USD |
25.81 bill. USD |
Free Float Market Cap.: |
- USD |
- USD |
Market Cap. / Employee: |
- USD |
- USD |
Shares Outstanding: |
73.3 mill. |
|
Profitability
Gross Profit Margin: |
38.28% |
EBIT Margin: |
22.92% |
Net Profit Margin: |
20.12% |
Return on Equity: |
20.60% |
Return on Assets: |
15.50% |
Financial Strength
Liquidity I / Cash Ratio: |
127.11% |
Liquidity II / Quick Ratio: |
203.32% |
Liquidity III / Current Ratio: |
288.24% |
Debt / Equity Ratio: |
32.92% |
Dynam. Debt / Equity Ratio: |
122.15% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
2023-12-31 |
Accounting Standard: |
US GAAP |